These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401 [TBL] [Abstract][Full Text] [Related]
4. SS-A/Ro antibodies in Chinese patients with systemic lupus erythematosus and Sjögren's syndrome. Tsay GJ; Wang CL; Chen TY; Huang CN; Hsu TC J Formos Med Assoc; 1996 Dec; 95(12):905-10. PubMed ID: 9000806 [TBL] [Abstract][Full Text] [Related]
5. Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate. Tanaka N; Muro Y; Sugiura K; Tomita Y Mod Rheumatol; 2008; 18(6):585-92. PubMed ID: 18633690 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus. Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526 [TBL] [Abstract][Full Text] [Related]
8. Reflections in the assessment of secondary Sjogren's syndrome. Hernández-Molina G; Avila-Casado C; Sánchez-Guerrero J Rheumatology (Oxford); 2011 Aug; 50(8):1519-21. PubMed ID: 21672968 [No Abstract] [Full Text] [Related]
9. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic. Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708 [TBL] [Abstract][Full Text] [Related]
10. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. Meyer O Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426 [TBL] [Abstract][Full Text] [Related]
11. Rheumatologic Tests: A Primer for Family Physicians. Ali Y Am Fam Physician; 2018 Aug; 98(3):164-170. PubMed ID: 30215901 [TBL] [Abstract][Full Text] [Related]
12. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus]. Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505 [TBL] [Abstract][Full Text] [Related]
13. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome. Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639 [TBL] [Abstract][Full Text] [Related]
14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
15. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Tan EM; Chan EK; Sullivan KF; Rubin RL Clin Immunol Immunopathol; 1988 May; 47(2):121-41. PubMed ID: 3280190 [TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica and non organ-specific autoimmunity. Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142 [TBL] [Abstract][Full Text] [Related]
17. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029 [TBL] [Abstract][Full Text] [Related]
18. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes]. Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267 [TBL] [Abstract][Full Text] [Related]
19. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands. Ter Borg EJ; Kelder JC Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402 [TBL] [Abstract][Full Text] [Related]